Scientists used a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated COPD and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors, of which they screened the function in lung organoids.
[Science Advances]